arrow
Back
D

D. Ross Camidge

University of Colorado System

110H-index
999Paper Count
6.3WCitation Count
Published Papers 209
Publication Date
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
errShare
errSave
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
err2025-08-19
err0
errOAAI
errAmin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang
errShare
errSave
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non–Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
err2025-06-06
err0
errOAAI
errLyudmila Bazhenova; J.G. Hodgson; D. Ross Camidge; Corey J. Langer; Rudolf M. Huber; Dong-Wan Kim; Karen L. Reckamp; Myung-Ju Ahn; Daniel S.W. Tan; Jyoti D. Patel; Sylvie Vincent; Cong Li; Michael J. Humphries; Pingkuan Zhang; Victor M. Rivera; Scott Gettinger
errShare
errSave
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials
err2025-03-01
err0
PREAI
errCamidge, D. Ross; Sugawara, Shunichi; Kondo, Masashi; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Kudou, Kentarou; Asato, Takayuki; Hupf, Bradley; Vranceanu, Florin; Fram, Robert J.; Ohe, Yuichiro; Popat, Sanjay
errShare
errSave
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
err2025-01-01
err0
errOAAI
errStalker, Margaret; Grady, Connor B.; Watts, Alex; Hwang, Wei-Ting; Chandrasekhara, Krishna; Sun, Fangdi; Liu, Geoffrey; Patel, Devalben; Nieva, Jorge; Herrmann, Amanda; Marrone, Kristen; Lam, Vincent K.; Velcheti, Vamsidhar; Liu, Stephen, V; Montenegro, Gabriela Liliana Bravo; Tompkins, William; Patil, Tejas; Weiss, Jared; Miller, Kelsey Leigh; Schwartzman, William; Dowell, Jonathan E.; Shaverdashvili, Khvaramze; Villaruz, Liza; Cass, Amanda; Iams, Wade; Aisner, Dara; Aggarwal, Charu; Camidge, D. Ross; Sun, Lova; Marmarelis, Melina E.
errShare
errSave
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
err2024-09-13
err3
errOAAI
errLin, Jessica J.; Horan, Joshua C.; Tangpeerachaikul, Anupong; Swalduz, Aurelie; Valdivia, Augusto; Johnson, Melissa L.; Besse, Benjamin; Camidge, D. Ross; Fujino, Toshio; Yoda, Satoshi; Nguyen-Phuong, Linh; Mizuta, Hayato; Bigot, Ludovic; Nobre, Catline; Lee, Jii Bum; Yu, Mi Ra; Mente, Scot; Sun, Yuting; Kohl, Nancy E.; Porter, James R.; Shair, Matthew D.; Zhu, Viola W.; Felip, Enriqueta; Cho, Byoung Chul; Friboulet, Luc; Hata, Aaron N.; Pelish, Henry E.; Drilon, Alexander
errShare
errSave
Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
err2024-09-01
err2
PREAI
errBesse, B.; Drilon, A. E.; Cho, B. C.; Camidge, D. R.; Neal, J.; Lin, C-C.; Liu, S. V.; Nagasaka, M.; Kao, S. C-H.; Felip, E.; Van der Wekken, A. J.; Lin, C. C.; Bauman, J. R.; Gadgeel, S.; Samant, M.; Shen, J.; Sun, Y.; Zhu, V. W.; Upadhyay, V. A.; Lin, J. J.
errShare
errSave
c-Met protein overexpression and telisotuzumab vedotin efficacy by biopsy age, type, and region in the LUMINOSITY phase II study
err2024-09-01
err0
PREAI
errBar, J.; Baijal, S.; Luo, A.; Zhang, N.; Ratajczak, C.; Ansell, P. J.; Lu, S.; Camidge, D. R.
errShare
errSave
ABBV-400, a c-Met protein-targeting antibody-drug conjugate (ADC), in patients (Pts) with advanced EGFR wildtype (WT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase I study
err2024-09-01
err1
PREAI
errDe Miguel, M.; Yamamoto, N.; Raimbourg, J.; Cho, B. C.; Gottfried, M.; Stemmer, S. M.; Goldman, J. W.; Blaney, M. E.; Jennaro, T.; Vasilopoulos, A.; Li, R. R.; Freise, K. J.; Aristide, M. R. Neagu; Morrison-Thiele, G.; Hunter, Z. N.; Burns, M.; Camidge, D. R.
errShare
errSave
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
err2024-08-01
err2
errOAAI
errTompkins, William; Grady, Connor B.; Hwang, Wei-Ting; Chandrasekhara, Krishna; Mccoach, Caroline; Sun, Fangdi; Liu, Geoffrey; Patel, Devalben; Nieva, Jorge; Herrmann, Amanda; Marrone, Kristen; Lam, Vincent K.; Velcheti, Vamsi; V. Liu, Stephen; Montenegro, Gabriela Liliana Bravo; Patil, Tejas; Weiss, Jared; Miller, Kelsey Leigh; Schwartzman, William; Dowell, Jonathan E.; Shaverdashvili, Khvaramze; Villaruz, Liza; Cass, Amanda; Iams, Wade; Aisner, Dara; Aggarwal, Charu; Camidge, D. Ross; Marmarelis, Melina E.; Sun, Lova
errShare
errSave
Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) plus chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial
err2024-04-05
err0
PREAI
errBar, Jair; Esteban, Emilio; Rodriguez-Abreu, Delvys; Ponce-Aix, Santiago; Szalai, Zsuzsanna; Felip, Enriqueta; Gottfried, Maya; Pulla, Mariano Provencio; Robinson, Andrew; Fulop, Andrea; Rao, Suman Bannur; Camidge, D. Ross; Speranza, Giovanna; Hunkapiller, Nathan; McDaniel, Robert; Jung, Byoungsok; Burkhardt, David; Mauntz, Ruth; Chen, Cai; Pena, Carol; Cristescu, Razvan; Dettman, Elisha J.; Townson, Steven M.; Kobie, Julie; Csoszi, Tibor
errShare
errSave
Assessment of tyrosine kinase inhibitor bypass mechanisms in lung cancer using single cell multiomics, patient derived organoids and rationally designed drug screens
err2024-03-22
err0
PREAI
errLiu, Liqiong; Strange, Ann; Lee, Schuyler; Gao, Bifeng; Merrick, Daniel; Patil, Tejas; DeGregori, James; Camidge, D. Ross; Pine, Sharon R.; Sabaawy, Hatim E.
errShare
errSave
Early activation of HGF-cMET serves as a bypass pathway to ALK and RET tyrosine kinase inhibitors in non-small cell lung cancer
err2024-03-22
err0
PREAI
errPatil, Tejas; Hinz, Trista; Pine, Sharon; Saabawy, Hatim; Bunn, Paul; Schenk, Erin L.; Camidge, Ross; Heasley, Lynn
errShare
errSave
Mobocertinib: Mechanism of action, clinical, and translational science
err2024-03-21
err9
errOAAI
errHanley, Michael J.; Camidge, D. Ross; Fram, Robert J.; Gupta, Neeraj
errShare
errSave
Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC
err2024-03-01
err0
errOAAI
errJennings, Elaine M.; Camidge, D. Ross; Gadgeel, Shirish; Barker, Scott
errShare
errSave
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
err2024-02-01
err5
errOAAI
errPatil, Tejas; Staley, Alyse; Nie, Yunan; Sakamoto, Mandy; Stalker, Margaret; Jurica, James M.; Koehler, Kenna; Cass, Amanda; Kuykendall, Halle; Schmitt, Emily; Filar, Emma; Reventaite, Evelina; Davies, Kurt D.; Nijmeh, Hala; Haag, Mary; Yoder, Benjamin A.; Bunn, Paul A.; Schenk, Erin L.; Aisner, Dara L.; Iams, Wade T.; Marmarelis, Melina E.; Camidge, D. Ross
errShare
errSave
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
err2024-01-11
err18
PREAI
errDrilon, Alexander; Camidge, D. Ross; Lin, Jessica J.; Kim, Sang-We; Solomon, Benjamin J.; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Juergen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G.; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul
errShare
errSave